General Steel Holdings, Inc. (GSIH) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerGeneral Steel Holdings, Inc. (GSIH) trades at $0.0006. General Steel Holdings, Inc. operates in the cell research and development sector within the People's Republic of China. The company focuses on cell storage and culture services. Sector: Materials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for GSIH: GSIH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
General Steel Holdings, Inc. (GSIH) Materials & Commodity Exposure
General Steel Holdings, Inc., headquartered in Beijing, China, is engaged in cell research, development, storage, and cell culture services. With a small team, the company operates within the Basic Materials sector, specifically focusing on innovative cell-based solutions in the Chinese market.
What Is the Investment Thesis for GSIH?
Investing in General Steel Holdings, Inc. presents a highly speculative opportunity given its small market capitalization of $0.00B and negative P/E ratio of -0.02. The company's focus on cell research and development in China could offer growth potential if it can successfully commercialize its technologies. However, the negative beta of -7.42 suggests extreme volatility. Key value drivers would include securing research grants, partnerships, or successful product launches. The absence of a dividend indicates a focus on reinvesting earnings, but the company's financial viability needs careful assessment. The OTC market listing introduces additional risks related to liquidity and transparency.
Based on FMP financials and quantitative analysis
GSIH Key Highlights
Market capitalization of $0.00B indicates a micro-cap company with limited market presence.
- Negative P/E ratio of -0.02 suggests the company is currently not profitable.
- Beta of -7.42 indicates extreme volatility relative to the market.
- No dividend yield reflects a focus on reinvesting earnings for growth.
- Operations are based in China, exposing the company to regulatory and economic factors specific to that region.
Who Are GSIH's Competitors?
GSIH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ZKIN ZK International Group Co., Ltd. | $1.74 | -3.38% | $9.88M | — |
| HUDI Huadi International Group Co., Ltd. | $0.70 | +2.37% | $10.0M | 35 5-pillar |
| INHD Inno Holdings Inc. | $3.18 | -0.93% | $14.4M | — |
| KBSX FST Corp. | $1.45 | -15.70% | $64.9M | 41 5-pillar |
| ACNT Ascent Industries Co. | $13.77 | -1.29% | $124M | 39 5-pillar |
| HLP Hongli Group Inc. | $2.47 | -3.14% | $185M | 59 5-pillar |
| FRD Friedman Industries, Incorporated | $42.39 | +3.20% | $306M | 59 5-pillar |
| ASTL Algoma Steel Group Inc. | $4.45 | +2.53% | $469M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GSIH's Key Strengths?
Focus on cell research and development.
- Location in Beijing, China.
- Potential for innovation in biotechnology.
- Cell storage and culture services
What Are GSIH's Weaknesses?
Small size and limited resources.
- Negative profitability.
- High volatility.
- OTC market listing.
What Are the Key Risks for GSIH?
Negative return on equity (-19.6%) — the business is not currently generating profit on shareholder capital.
- Insider selling — insiders were net sellers of roughly $1.5M recently.
- Competition from larger, more established biotechnology companies.
- Regulatory changes in China affecting the biotechnology sector.
- Economic downturns impacting research funding and healthcare spending.
- Limited financial resources and negative profitability.
- High volatility and liquidity risks associated with OTC market listing.
What Are GSIH's Competitive Advantages?
- Proprietary cell-based technologies (if any).
- Established relationships with research institutions (if any).
- Specialized expertise in cell research and development.
- Strategic location in Beijing, China.
What Does GSIH Do?
General Steel Holdings, Inc., established in 2002 and based in Beijing, China, is involved in cell research, development, storage, and cell culture services. The company's operations are concentrated within the People's Republic of China. While the name suggests a focus on steel, the company's actual activities revolve around the biotechnology sector, specifically cell-based services. This discrepancy may reflect a historical business model that has since evolved. The company's services potentially cater to research institutions, healthcare providers, or pharmaceutical companies requiring cell-based solutions. Given its small size of 5 employees, General Steel Holdings likely operates on a relatively small scale, possibly focusing on niche areas within the broader cell research market. The company's competitive positioning is unclear without further data on its specific cell-based technologies and market share within China.
What Products and Services Does GSIH Offer?
- Engages in cell research and development.
- Provides cell storage services.
- Offers cell culture services.
- Operates within the People's Republic of China.
- Focuses on the biotechnology sector.
- Potentially caters to research institutions and healthcare providers.
How Does GSIH Make Money?
- Generates revenue through cell research and development projects.
- Earns income from cell storage services.
- Provides cell culture services for a fee.
- Potentially secures research grants and funding.
What Industry Does GSIH Operate In?
General Steel Holdings, Inc. operates in the Basic Materials sector, specifically within the steel industry, although its primary business is cell research and development. The global steel market is influenced by factors such as infrastructure development, automotive production, and construction activity. The cell research and development industry is experiencing growth due to advancements in biotechnology and increasing demand for cell-based therapies. Competitors in the steel industry include AFML (AFL Materials), CCOB (Cobra Acquisition Corporation), CLTH (Clothoid Biomedical Inc), CNTO (Cenntro Electric Group Limited), and DANR (Danimer Scientific Inc.). General Steel Holdings' positioning within these sectors is unclear given its small size and dual focus.
Who Are GSIH's Key Customers?
- Research institutions requiring cell-based solutions.
- Healthcare providers utilizing cell therapies.
- Pharmaceutical companies involved in drug development.
- Hospitals needing cell storage services.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Insider Activity
12 transactions · 0 purchases, 3 sales, 9 other transactions · 7 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Key Financial Metrics
Return on equity for General Steel Holdings, Inc. stands at -19.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -6.7%, showing how much profit it generates from its asset base. A current ratio of 0.50 means current liabilities exceed short-term assets, a liquidity point worth watching.
Earnings Track Record
General Steel Holdings, Inc. has beaten Wall Street's EPS estimate in 5 of its last 8 reported quarters — more hits than misses. Reported results have landed about 7.0% below estimates on average.
Company Profile
General Steel Holdings, Inc. operates in the Steel industry within the Basic Materials sector. It is headquartered in Beijing, CN. The company is led by CEO Baoning Shi. GSIH has traded publicly since 2004.
GSIH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
GSIH Latest News
-
General Steel (OTCMKTS:GSIH) Shares Pass Above 200-Day Moving Average – Time to Sell?
defenseworld.net · Aug 12, 2026
GSIH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GSIH.
Price Targets
Wall Street price target analysis for GSIH.
GSIH MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GSIH; grades run from A+ (80-100) to F (below 30).
Leadership: Baoning Shi
CEO
Baoning Shi is the CEO of General Steel Holdings, Inc. and manages a team of 5 employees. Information regarding Mr. His leadership is focused on guiding the company's strategic direction in the cell research, development, storage, and cell culture service sectors within China.
Track Record: The company's current focus on cell research and development suggests a potential shift in business strategy under his leadership. Further information is needed to assess his impact on the company's performance and growth.
GSIH OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that General Steel Holdings, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure, may be thinly traded, and carry a higher degree of risk compared to companies listed on major exchanges like the NYSE or NASDAQ. Investors should exercise extreme caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Limited financial disclosure increases information asymmetry.
- Low trading volume and liquidity can lead to price volatility.
- Higher potential for fraud and manipulation.
- Lack of regulatory oversight compared to major exchanges.
- Going concern risk due to financial instability.
- Verify the company's legal registration and compliance status.
- Review available financial statements and assess their accuracy.
- Research the background and experience of the company's management team.
- Evaluate the company's business model and competitive landscape.
- Assess the company's cash flow and ability to meet its financial obligations.
- Understand the risks associated with the OTC market and the specific company.
- Consult with a qualified financial advisor.
- Consistent business operations since 2002.
- Focus on cell research and development.
- Headquarters located in Beijing, China.
- Active engagement in cell storage and culture services.
What Investors Ask About General Steel Holdings, Inc. (GSIH) — Materials
What does General Steel Holdings, Inc. do?
General Steel Holdings, Inc. is involved in cell research, development, storage, and cell culture services within the People's Republic of China.
What do analysts say about GSIH stock?
There is currently no available analyst coverage for General Steel Holdings, Inc. due to its small market capitalization and OTC listing.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- OTC market listing introduces additional risks and uncertainties.